Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients

Conditions:   End Stage Renal Disease;   Peritoneal Dialysis Interventions:   Drug: Spironolactone;   Drug: Losartan Sponsor:   Chiang Mai University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials